WSCC yields 181.82% · JNJ yields 2.14%● Live data
📍 WSCC pulled ahead of the other in Year 1
Combined, WSCC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WSCC + JNJ for your $10,000?
Waterside Capital Corporation is no longer investing. It is a venture capital, and private equity firm specializing in investments in mezzanine debt for growth expansion; management buyouts; recapitalizations; leveraged buyouts; acquisitions; and working capital. The firm also provides bridge financing. It seeks to invest in small private and public companies and small middle market companies. The firm does not invest in start-ups, turnaround situations, oil or gas exploration, real estate development, and direct lending businesses. The firm prefers to invest in companies based in the Mid-Atlantic region and also invests in small businesses based in Richmond, Hampton Roads, Virginia, Washington D.C., North Carolina, and Maryland. The firm prefers to provide, with a more than five year term with flexible amortization, between $500,000 and $3 million as subordinate loans and between $1 million and $3 million as senior debt financing. It prefers to invest in companies that have annual revenues greater than $5 million. The firm co-invests in case of large investments and prefers to structure its investments as debt with attached warrants on common stock or as senior debts. The firm prefers equity participation when it provides subordinate loans and a collateral of assets while providing senior debt financing. Westside Capital Corporation was founded in 1993 and is based in Virginia Beach, Virginia.
Full WSCC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.